The Elecsys HIV combi PT assay, Roche Holding's fourth-generation HIV combination antigen-antibody assay, has been granted approval by the FDA. The assay, which can aid in the detection of HIV-1 and HIV-2 infection, is designed for use in in vitro qualitative determination of antibodies to HIV-1 and HIV-2 and HIV-1 p24 antigen in human serum and plasma.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.